Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Juli 2025 12:15 ET | Quelle: Monteverde & Associates PC

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Onconetix, Inc. (NASDAQ: ONCO)

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for...
04. September 2024 07:30 ET | Quelle: Plus Therapeutics Inc.

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
19. August 2019 08:24 ET | Quelle: Oncology Pharma, Inc.

Update: Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide License and Co-Development of Its Broad-Spectrum Anti-Cancer Drug, KTH 222

SAN FRANCISCO, CA, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Oncology Pharma (OTCPK: ONPH)is pleased to announce that it signed a Letter of Intent with Kalos Therapeutics (Phoenix, AZ)...